IRIS
CUCINOTTA, Domenico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.167
EU - Europa 14.795
AS - Asia 7.211
SA - Sud America 2.780
AF - Africa 242
Continente sconosciuto - Info sul continente non disponibili 239
OC - Oceania 14
Totale 40.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.834
RU - Federazione Russa 7.205
SG - Singapore 3.030
BR - Brasile 2.392
CN - Cina 2.147
IE - Irlanda 1.867
SE - Svezia 1.566
DE - Germania 965
HK - Hong Kong 731
UA - Ucraina 709
IT - Italia 679
FR - Francia 589
FI - Finlandia 447
VN - Vietnam 422
GB - Regno Unito 382
IN - India 206
CA - Canada 137
AR - Argentina 128
BD - Bangladesh 110
MX - Messico 84
PL - Polonia 83
TR - Turchia 83
IQ - Iraq 72
EC - Ecuador 69
ZA - Sudafrica 65
BE - Belgio 52
AT - Austria 51
VE - Venezuela 49
ID - Indonesia 47
MA - Marocco 47
JP - Giappone 43
NL - Olanda 41
CO - Colombia 40
ES - Italia 36
UZ - Uzbekistan 36
PK - Pakistan 35
PY - Paraguay 31
CI - Costa d'Avorio 28
KE - Kenya 28
IR - Iran 26
UY - Uruguay 26
JM - Giamaica 24
TN - Tunisia 22
CL - Cile 21
CH - Svizzera 20
JO - Giordania 20
AE - Emirati Arabi Uniti 19
AZ - Azerbaigian 19
PE - Perù 18
CZ - Repubblica Ceca 17
DZ - Algeria 16
IL - Israele 16
SA - Arabia Saudita 16
MY - Malesia 15
HN - Honduras 14
NP - Nepal 14
EG - Egitto 13
LB - Libano 13
CR - Costa Rica 12
KR - Corea 12
PH - Filippine 11
TT - Trinidad e Tobago 11
GE - Georgia 10
LV - Lettonia 9
AL - Albania 8
AU - Australia 8
GT - Guatemala 8
KZ - Kazakistan 8
DO - Repubblica Dominicana 7
PS - Palestinian Territory 7
RO - Romania 7
SY - Repubblica araba siriana 7
BB - Barbados 6
EE - Estonia 6
LT - Lituania 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
ET - Etiopia 5
EU - Europa 5
GR - Grecia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
QA - Qatar 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BG - Bulgaria 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NG - Nigeria 4
NI - Nicaragua 4
OM - Oman 4
PT - Portogallo 4
SV - El Salvador 4
TH - Thailandia 4
BY - Bielorussia 3
Totale 40.168
Salva come PNG Salva come JPEG
Città #
Moscow 2.180
Ashburn 2.026
Dublin 1.862
Singapore 1.614
Jacksonville 1.433
Dallas 1.301
Chandler 1.259
San Jose 843
Nyköping 757
Hong Kong 724
Beijing 717
Council Bluffs 541
Princeton 339
Cambridge 332
The Dalles 323
Lauterbourg 302
Dearborn 297
Los Angeles 292
Des Moines 269
Medford 255
Boardman 232
Munich 211
São Paulo 196
Ann Arbor 195
New York 181
Buffalo 160
Bremen 141
Messina 138
Ho Chi Minh City 133
Tianjin 104
Jinan 97
Hanoi 90
Woodbridge 90
San Mateo 86
Wilmington 86
Shenyang 84
Redondo Beach 81
Lancaster 78
Helsinki 75
Warsaw 75
Rio de Janeiro 74
Santa Clara 65
Pune 63
Orem 58
Belo Horizonte 57
Frankfurt am Main 56
Atlanta 55
Curitiba 51
Nanjing 51
Brussels 50
Brooklyn 49
Guangzhou 47
Houston 47
Turku 47
Columbus 45
Chicago 43
Rome 42
Montreal 41
Tokyo 41
Zhengzhou 41
Hebei 40
San Francisco 40
Vienna 39
Phoenix 38
Chennai 37
Porto Alegre 36
Ningbo 35
Tashkent 35
Brasília 34
Hangzhou 34
Johannesburg 33
Boston 32
Düsseldorf 30
Milan 30
Norwalk 30
Quito 30
Denver 29
Haikou 29
Abidjan 28
Salvador 28
Nairobi 26
Seattle 26
Shanghai 25
Baghdad 24
Campinas 24
Goiânia 24
Manchester 24
Taizhou 24
Guayaquil 23
London 23
Da Nang 22
Montevideo 22
Nanchang 22
Nuremberg 22
Augusta 21
Guarulhos 21
Shenzhen 21
Amsterdam 20
Ankara 20
Manaus 20
Totale 22.343
Salva come PNG Salva come JPEG
Nome #
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 343
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). 329
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 314
Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. 280
A DECREASED BRAIN-STEM CONTENT OF GABA MEDIATES HYPERINSULINEMIA IN OBESE ZUCKER RATS 270
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 262
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 244
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 239
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 226
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 226
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 223
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 210
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 209
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 208
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse 206
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 206
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 204
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 200
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 200
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 199
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 199
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 194
Secrezione insulinica e tolleranza glucidica in dislipidemici e loro modificazioni dopo trattamento ipolipemizzante. 194
Cardiovascular effects of raloxifene hydrochloride 193
Multiple osteoporotic fractures complicating Wolfram syndrome 193
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 193
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 190
Altered platetel magnesium and urinary soluble form of intercellular adhesion molecule concentrations in insulin dependent diabetes mellitus patients with microalbuminuria 187
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 185
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 183
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 181
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 180
Autoantibodies against cytokeratin 19 in patients with type 1 diabetes mellitus 179
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 179
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. 179
[Circadian variations of T3 and T4 in euthyroid subjects]. 178
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 175
[beta-Adrenergic blockade and circadian variations of IRI]. 172
Anti-p53 autoantibodies in patients with IDDM 171
Correlates of total homocysteine plasma concentration in type 2 diabetes 169
[Blood cortisol changes due to insulin hypoglycemia and serum renin dynamics in the cold pressor test in normal and hypertensive subjects]. 169
SERUM ACTIVITY OF BETA- N-ACETYLGLUCOSAMINIDASE IN OBESE HYPERINSULINEMIC SUBJECTS. 168
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 168
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 167
Age and metabolic control influence lens opacity in IDDM patients 165
[Behavior of alpha 2-macroglobulin and alpha 1-antitrypsin in mature diabetics]. 165
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 165
[Circadian variations of immunoreactive insulin and beta-receptors blockade]. 163
Age and metabolic control influence lens opacity in IDDM patients. 162
Calcio e secrezione endocrina pancreatica Nota III. Efffetti di una infusione di calcio sulla secrezione glucagonica da ipoglicemia insulinica. 162
[Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics]. 162
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 162
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 162
ADULT HEIGHT EXCEEDING TARGET HEIGHT IN A PATIENT WITH CONGENITAL PANHYPOPITUITARISM DIAGNOSED AFTER THE AGE OF 25 YEARS 161
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 161
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 160
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 160
[Behavior of plasma renin activity (PRA) after administration of a calcium antagonist]. 160
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. 158
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 158
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 158
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury 157
SERUM URINARY ACTIVITIES OF b-N-ACETYLGLUCOSAMINIDASE AND b-GLUCURONIDASE IN DIABETIC PATIENTS. 157
[P.R.A. and cold pressor test following beta receptor block during arterial hypertensive syndromes]. 157
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 156
Valutazione delle apoproteine A e B, delle lipoproteine e dei lipidi plasmatici durante trattamento con benzafribato in varie forme di iperlipoproteinemia. 156
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 156
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 154
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 154
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 153
[Circadian variations in glycemia and IRI in normal subjects, young and adult diabetics and in obese subjects]. 153
A multicenter study on the prevalence of diabetic neuropathy in Italy 152
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 152
Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major 150
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 150
[Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients]. 150
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 149
[Fibrinolysis and the cold pressor test]. 149
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 148
[Circadian variations in blood cortisol and the rapid inhibition test with dexamethasone in primary and secondary hypertension patients]. 147
[Hypertriglyceridemia, IRI and platelet aggregation]. 147
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2 147
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 147
[Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation]. 146
[Thyroid hormones and adrenergic stimulation. II. TSH and reverse T3 behavior]. 146
[Behavior of plasma renin activity (PRA) after administration of DOCA in normal subjects]. 145
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 145
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 145
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 144
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 143
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 143
Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia 142
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 142
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 142
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 142
Glucose tolerance,insulin secretion and peripheral sensitivity in thalassemia major 141
[Calcium and endocrine pancreas secretion. I. Effects of an infusion of calcium on plasma levels of insulin and glucagon]. 141
beta-Adrenergic blockade and circadian variations of IRI 141
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 141
Livelli di TSH e parametri metabolici in soggetti diabetici di tipo 2 eutiroidei 140
Totale 17.658
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.787 0 0 0 84 52 7 148 87 44 447 264 654
2022/20235.338 427 360 216 398 521 519 37 339 2.280 32 163 46
2023/20241.238 88 218 90 115 93 301 20 68 18 34 12 181
2024/20255.869 72 49 102 318 286 167 129 1.387 1.594 324 491 950
2025/202616.694 757 1.150 1.369 1.289 1.323 3.838 1.964 1.968 1.969 563 252 252
2026/20273.086 264 960 848 1.014 0 0 0 0 0 0 0 0
Totale 40.448